Suppr超能文献

中度分化肝细胞癌患者预后评估中的病理特征、增殖细胞核抗原标记指数及DNA指数

Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma.

作者信息

Zeng Wen-Jiao, Liu Guo-Yuan, Xu Jie, Zhou Xin-Da, Zhang Yue-E, Zhang Nong

机构信息

Department of Pathology, Medical School of Fudan University, Shanghai, China.

出版信息

World J Gastroenterol. 2002 Dec;8(6):1040-4. doi: 10.3748/wjg.v8.i6.1040.

Abstract

AIM

To study the relationship between prognosis and pathological characteristics, proliferating cell nuclear antigen labeling index (PCNA-LI) and DNA index (DI) in patients with moderately differentiated hepatocellular carcinoma(HCC).

METHODS

51 cases of moderately differentiated HCC were analyzed with respect to the relation between their clinical follow-up data and pathological characteristics. Meanwhile, PCNA-LI of HCC cells was detected by immunohistochemistry assay and DI was measured by Feulgen staining and automatic image analysis technique.

RESULTS

Patients with a single tumor nodule, less than 5 cm in diameter, no tumor emboli, no daughter nodules and necrosis had relatively better prognosis; patients with euploidy HCC had better prognosis than those with aneuploidy; among the aneuploidy patients those with DI<1.5 had better prognosis than the cases with DI>1.5; The higher the PCNA-LI, the worse would be the prognosis. The increase in DI was correlated with the increase in PCNA-LI, and both of them were correlated with the pathological changes of the tumor.

CONCLUSION

A composite analysis of the pathological characteristics of tumor tissue, DI and PCNA-LI might be useful in predicting the prognosis of HCC patients.

摘要

目的

研究中度分化肝细胞癌(HCC)患者的预后与病理特征、增殖细胞核抗原标记指数(PCNA-LI)及DNA指数(DI)之间的关系。

方法

对51例中度分化HCC患者的临床随访资料与病理特征之间的关系进行分析。同时,采用免疫组织化学法检测HCC细胞的PCNA-LI,并用Feulgen染色和自动图像分析技术测定DI。

结果

肿瘤结节为单个、直径小于5 cm、无肿瘤栓子、无子结节及坏死的患者预后相对较好;二倍体HCC患者的预后优于非整倍体患者;在非整倍体患者中,DI<1.5者的预后优于DI>1.5者;PCNA-LI越高,预后越差。DI的升高与PCNA-LI的升高相关,且二者均与肿瘤的病理变化相关。

结论

对肿瘤组织的病理特征、DI及PCNA-LI进行综合分析可能有助于预测HCC患者的预后。

相似文献

6
Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen.
Cancer. 1995 Aug 1;76(3):399-405. doi: 10.1002/1097-0142(19950801)76:3<399::aid-cncr2820760309>3.0.co;2-o.
8
Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia.
Cancer. 1993 Nov 15;72(10):2902-9. doi: 10.1002/1097-0142(19931115)72:10<2902::aid-cncr2820721008>3.0.co;2-2.

引用本文的文献

1
Molecular subtyping in colorectal cancer: A bridge to personalized therapy (Review).
Oncol Lett. 2023 Apr 18;25(6):230. doi: 10.3892/ol.2023.13816. eCollection 2023 Jun.
2
β-carotene Regulates the Murine Liver Microenvironment of a Metastatic Neuroblastoma.
J Cancer Prev. 2013 Dec;18(4):337-45. doi: 10.15430/jcp.2013.18.4.337.
3
Asymmetric cell division in polyploid giant cancer cells and low eukaryotic cells.
Biomed Res Int. 2014;2014:432652. doi: 10.1155/2014/432652. Epub 2014 Jun 22.
4
Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma.
Med Oncol. 2008;25(3):341-5. doi: 10.1007/s12032-008-9042-6. Epub 2008 Jan 23.
5
Serum tumor markers for detection of hepatocellular carcinoma.
World J Gastroenterol. 2006 Feb 28;12(8):1175-81. doi: 10.3748/wjg.v12.i8.1175.
7
Construction and expression of recombined human AFP eukaryotic expression vector.
World J Gastroenterol. 2003 Jul;9(7):1465-8. doi: 10.3748/wjg.v9.i7.1465.
8
Effect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxity.
World J Gastroenterol. 2003 May;9(5):930-5. doi: 10.3748/wjg.v9.i5.930.
9
Detection of HBV, PCNA and GST-pi in hepatocellular carcinoma and chronic liver diseases.
World J Gastroenterol. 2003 Mar;9(3):459-62. doi: 10.3748/wjg.v9.i3.459.

本文引用的文献

4
A role for matrix metalloproteinases and tumor host interaction in hepatocellular carcinomas.
Am J Surg. 2002 May;183(5):588-94. doi: 10.1016/s0002-9610(02)00833-4.
5
The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma.
Mol Cell Endocrinol. 2002 Feb 22;187(1-2):39-45. doi: 10.1016/s0303-7207(01)00709-2.
8
Hepatocellular carcinoma--cause, treatment and metastasis.
World J Gastroenterol. 2001 Aug;7(4):445-54. doi: 10.3748/wjg.v7.i4.445.
9
Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein.
World J Gastroenterol. 2001 Feb;7(1):28-32. doi: 10.3748/wjg.v7.i1.28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验